期刊文献+

Sr-HAP/CS复合凝胶的制备及生物矿化性能研究 被引量:1

Studies on preparation and biomineralization performance of Sr-HAP/CS composite gel
下载PDF
导出
摘要 采用化学沉淀法-冷冻干燥法制备含锶羟基磷灰石/壳聚糖(Sr-HAP/CS)复合凝胶,比较羟基磷灰石/壳聚糖(HAP/CS)凝胶,研究了它们的组成、结构和生物矿化性能。产物经IR、XRD和SEM分析证实:HAP/CS和SrHAP/CS中无新化学键生成,主要成分为HAP、Sr-HAP和CS;XRD中Sr-HAP的特征峰比HAP相应峰尖锐,晶体粒径减小;2种凝胶内部为网状孔隙结构,物相分布均匀。矿化实验结果表明,2种复合凝胶在模拟体液(SBF)中浸泡,表面发生钙的溶解和沉积现象;15 d后,凝胶表面有明显白色絮状物,主要为HAP类物质,且Sr-HAP/CS凝胶表面沉积物量较多;复合凝胶均具有诱导成骨性,Sr-HAP/CS对促进无机成骨物的生长作用较强。 Strontium-doped hydroxyapatite/chitosan composite gel(Sr-HAP/CS) was prepared by chemical precipitationfreeze-drying process.Compared with hydroxyapatite/chitosan gel(HAP/CS),their compositions,structures,and biomineralization performances were studied.The products were confirmed by IR,XRD,and SEM analysis:The HAP/CS and Sr-HAP/CS were mainly constitutive of HAP,Sr-HAP,and CS,and there was no new chemical bonds formed.Sr-HAP characteristic peak in XRD was sharp than HAP,and its crystal diameter decreased.The internal structure of two kinds of gel present reticular and pore on disperse uniformly.Results showed that the mineralized experiment,dissolution,and deposition of calcium on surface were produced for two kinds of compound gel soaked in simulated body fluid(SBF).After 15 d the gel surface had obvious white flocks which were mainly the HAP,and Sr-HAP/CS′s was more in quantity.Compound gel had induced into osseous,and the promotion effect of Sr-HAP/CS to the growth of inorganic osteogenesis content was stronger.
出处 《无机盐工业》 CAS 北大核心 2016年第8期26-29,共4页 Inorganic Chemicals Industry
基金 贵州省科学技术基金项目(黔科合J字2013-2131) 贵州大学教改项目(JG2013052)
关键词 Sr-HAP CS 复合凝胶 表征 矿化性能 Sr-HAP CS composite gel characterization mineralization performance
  • 相关文献

参考文献8

二级参考文献61

  • 1张玉梅,王勤涛,付涛,徐可为.含锶羟基磷灰石的湿法合成与结构稳定性[J].稀有金属材料与工程,2004,33(10):1049-1051. 被引量:8
  • 2郭大刚,徐可为,憨勇.理想化学配比掺锶羟基磷灰石的热稳定性[J].稀有金属材料与工程,2006,35(3):379-382. 被引量:7
  • 3林英光,杨卓如,程江.溶胶-凝胶结合超临界流体干燥法制备纳米掺锶羟基磷灰石的研究[J].高校化学工程学报,2007,21(3):454-459. 被引量:3
  • 4Shi Donglu. Introduction to Biomaterials. Beijing: Tsinghua University Press. 2006: 16-28.
  • 5Blake GM, Fogelman I. Long-term effect of strontium ranelate treatment on BMD. J. Bone Miner. Res., 2005, 20(11): 1901-1904.
  • 6Hott M, Deloffre P, Tsouderos Y, et al. $12911-2 reduces bone loss induced by short-term immobilization in rats. Bone, 2003, 33(1): 115-123.
  • 7Compston J. Prevention of vertebral fractures by strontium ranelate in postmenopausal women with osteoporosis. Osteoporos Int., 2005, 16(suppl 1): 4-6.
  • 8Kendler D L. Strontium ranelate-data on vertebral and nonvertebral fracture efficacy and safety: mechanism of action. Curr. Osteoporos Rep., 2006, 4(1): 34-39.
  • 9Okaayama S, Akao M, Nakamura S, et al. The mechanical properties and solubility of strontium substituted hydroxyapatite. Biomed. Mater Eng., 1991, 1(1): 11-17.
  • 10Donazzon B, Dechambre G, Lacout J. Calcium-strontium hydroxyapatite hydrothermal preparation. Ann. Chim. Sci. Mat., 1998,23(1/2): 53-56.

共引文献28

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部